MB Canno Biosciences Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 2,335 |
| - |
| 90 |
| 90 |
| - |
| 91.09 |
| 3.85 |
| 2,975 |
| 0 |
| 0 |
| 2,975 |
| 2023 |
|---|
| 4,283 |
| - |
| -1,385 |
| -1,385 |
| - |
| 73.38 |
| -32.34 |
| 3,318 |
| 200 |
| 0 |
| 3,518 |
| 2024 |
|---|
| 1,070 |
| - |
| 759 |
| 759 |
| - |
| 81.87 |
| 70.93 |
| 4,077 |
| 0 |
| 0 |
| 4,077 |
Register and
explore Okredo data| 2024 |
|---|
| 1,070 |
| - |
| 759 |
| 759 |
| - |
| 81.87 |
| 70.93 |
| 4,077 |
| 0 |
| 0 |
| 4,077 |
Register and
explore Okredo data2024
Turnover (€)
1,070 €
-75 % *
Sales per employee (€)
-Profit before tax (€)
759 €
155 % *
Net Profit (€)
759 €155 % *
Profit per employee (€)
-Total profitability (%)
81.87 %11.57 % *
Net profitability (%)
70.93 %319.33 % *
Equity (€)
4,077 €23 % *
Amounts Payable And Liabilities (€)
0 €
-100 % *
Non-current Assets (€)
0 €
- *
CurrentAssets (€)
4,077 €
16 % *